Telix Pharmaceuticals reports Q2 revenue of US$247M
Telix Pharmaceuticals (ASX:TLX) generated US$247 million in group revenue for the second quarter ended June 30.
Telix Pharmaceuticals (ASX:TLX) generated US$247 million in group revenue for the second quarter ended June 30.
Fintech lender Plenti Group (ASX:PLT) achieved record quarterly loan originations of $536 million for the quarter ended June 30.
HUB24 (ASX:HUB) announced record annual platform net inflows of $18.9 billion for FY26.
DevEx Resources (ASX:DEV) commenced a 17,000-metre reverse circulation and diamond drilling at its Nabarlek Uranium Project.
Alkane Resources (ASX:ALK) delivered Q4 gold equivalent production of 42,491 ounces, boosting its total cash balance to $454 million.
Tower (ASX:TWR) has appointed Len Elikhis as CFO, subject to the completion of regulatory processes.
Federal Labor backbenchers and union leaders have mounted a push to introduce a new tax on gas export revenue.
The CPSU urges the Federal Government to end KPMG audit contracts following internal data misuse and staff fines.
Botala Energy (ASX:BTE) begins commercial production testing at its Pitse Pilot well 3.5B in Botswana.
Imax CEO Richard Gelfond discusses the success of "The Odyssey" and the tech driving the company forward. "The Odyssey," the new movie from director Christopher Nolan, was the No. 1 film in the US and Canada over the weekend with $124.5 million in ticket sales.
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Katie Greifeld, Sally Bakewell, Carol Massar and Tim Stenovec.
Rebecca Venter, senior fixed income client portfolio manager at Vanguard, joins Scarlet Fu, Katie Greifeld, and Eric Balchunas on "Bloomberg ETF IQ." They discuss that according to Vanguard about 88% of Millennials and Gen Z prefer ETFs over mutual funds.